RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Luis M. Vilá to Quality of Life

This is a "connection" page, showing publications Luis M. Vilá has written about Quality of Life.
Connection Strength

0.830
  1. Cintr?n D, Alanis JM, ?lvarez-Villalobos N, Rodr?guez-Guti?rrez R, Vil? LM. A systematic review of pharmacological therapies and their effectiveness on health-related quality of life outcomes in patients with juvenile-onset systemic lupus erythematosus. Lupus. 2020 Mar; 29(3):303-310.
    View in: PubMed
    Score: 0.456
  2. Borgia RE, Ugarte-Gil MF, Vil? LM, Reveille JD, McGwin G, Alarc?n GS. Health-Related Quality of Life in Adults With Adolescent- and Adult-Onset Systemic Lupus Erythematosus: A Longitudinal Study of a Multiethnic US Cohort. Arthritis Care Res (Hoboken). 2023 07; 75(7):1416-1422.
    View in: PubMed
    Score: 0.140
  3. Font YM, Castro-Santana LE, Nieves-Plaza M, Maldonado M, Mayor AM, Vil? LM. Factors associated with regional rheumatic pain disorders in a population of Puerto Ricans with diabetes mellitus. Clin Rheumatol. 2014 Jul; 33(7):995-1000.
    View in: PubMed
    Score: 0.075
  4. Sanchez ML, McGwin G, Dur?n S, Fern?ndez M, Reveille JD, Vil? LM, Alarc?n GS. Factors predictive of overall health over the course of the disease in patients with systemic lupus erythematosus from the LUMINA cohort (LXII): use of the SF-6D. Clin Exp Rheumatol. 2009 Jan-Feb; 27(1):67-71.
    View in: PubMed
    Score: 0.053
  5. Alarc?n GS, McGwin G, Uribe A, Friedman AW, Roseman JM, Fessler BJ, Bastian HM, Baethge BA, Vil? LM, Reveille JD. Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course. Arthritis Rheum. 2004 Jun 15; 51(3):465-74.
    View in: PubMed
    Score: 0.039
  6. Jolly M, Sehgal V, Arora S, Azizoddin D, Pinto B, Sharma A, Devilliers H, Inoue M, Toloza S, Bertoli A, Blazevic I, Vil? LM, Moldovan I, Torralba KD, Mazzoni D, Cicognani E, Hasni S, Goker B, Haznedaroglu S, Bourre-Tessier J, Navarra SV, Clarke A, Weisman M, Wallace D, Mok CC. Does hydroxychloroquine improve patient reported outcomes in patients with lupus? Lupus. 2021 Oct; 30(11):1790-1798.
    View in: PubMed
    Score: 0.032
  7. Tucker LB, Uribe AG, Fern?ndez M, Vil? LM, McGwin G, Apte M, Fessler BJ, Bastian HM, Reveille JD, Alarc?n GS. Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus. 2008 Apr; 17(4):314-22.
    View in: PubMed
    Score: 0.013
  8. Fern?ndez M, Alarc?n GS, McGwin G, Sanchez ML, Apte M, Vil? LM, Reveille JD. Using the Short Form 6D, as an overall measure of health, to predict damage accrual and mortality in patients with systemic lupus erythematosus: XLVII, results from a multiethnic US cohort. Arthritis Rheum. 2007 Aug 15; 57(6):986-92.
    View in: PubMed
    Score: 0.012
  9. Chaiamnuay S, Bertoli AM, Fern?ndez M, Apte M, Vil? LM, Reveille JD, Alarc?n GS. The impact of increased body mass index on systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA XLVI) [corrected]. J Clin Rheumatol. 2007 Jun; 13(3):128-33.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support